概述
-
货号
KDJ63101
-
检测方法
Colorimetric -
样本类型
Plasma, Serum -
实验类型
Quantitative -
检测范围
0.31-5 μg/mL -
灵敏度
0.156 μg/ml -
精准度
CV<20%
-
回收率
80-120% -
运输
2-8 ℃ -
稳定性和存储
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. -
别名
LY-3074828, CAS: 1884201-71-1
-
背景
Mirikizumab (Eli Lilly and Company), Risankizumab (Boehringer Ingelheim and AbbVie), Tildrakizumab (Sun Pharma), Brazikumab (AstraZeneca), and Guselkumab (Janssen Biotech Inc.) are other drugs which target IL-23 and received the FDA approval for the treatment of psoriasis.
图片
参考文献
评价
